Cipla said supplies of its key US drug Lanreotide will remain constrained after its manufacturing partner paused production ...
Cipla has received the Food and Drug Administration’s blessing for lanreotide injection 120 mg/0.5 ml, 90 mg/0.3 ml, 60 mg/0.2 ml, which is the generic of somatuline depot (lanreotide) injection.
Clinical Benefit and Expedited Approval of Cancer Drugs in the United States, European Union, Switzerland, Japan, Canada, and Australia Randomized, single-blinded study. Patients with NETs received ...
MISSISSAUGA, ON, Jan. 7, 2020 /CNW/ - Ipsen Biopharmaceuticals Canada Inc. today announced the availability of a new delivery system for Somatuline ® Autogel ® (lanreotide injection) 60, 90, and 120 ...
Long-Term Update of US GI Intergroup RTOG 98-11 Phase III Trial for Anal Carcinoma: Survival, Relapse, and Colostomy Failure With Concurrent Chemoradiation Involving Fluorouracil/Mitomycin Versus ...
Afinitor plus Somatuline significantly improved PFS in GEP-NETs compared to Afinitor monotherapy, with median PFS of 29.7 vs. 11.5 months. The combination therapy showed a higher objective response ...
NDTV Profit on MSN
Sun Pharma, Cipla Recall Products In US: FDA
The US is the world's largest market for pharmaceutical products.
Cipla shares fell sharply after the U.S. Food and Drug Administration (USFDA) flagged multiple compliance lapses at Pharmathen International SA, the third party contract manufacturer that supplies the ...
Drugmakers Sun Pharma and Cipla are recalling products in the US due to manufacturing related issues, according to the US ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results